Simplex Trading, LLC Gamida Cell Ltd. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$0.85 - $1.87 $23,681 - $52,098	27,860 New	27,860 $28,000
Q4 2022 Feb 02, 2023	SELL	$1.15 - $2.1 $6,004 - $10,964	-5,221 Reduced 66.03%	2,686 $3,000
Q3 2022 Nov 04, 2022	BUY	$1.53 - $3.39 $4,369 - $9,681	2,856 Added 56.54%	7,907 $12,000
Q2 2022 Aug 03, 2022	SELL	$1.73 - $4.29 $100,085 - $248,189	-57,853 Reduced 91.97%	5,051 $8,000
Q1 2022 May 02, 2022	BUY	$2.22 - $4.47 $63,893 - $128,651	28,781 Added 84.34%	62,904 $261,000

Q4 2021 Feb 23, 2022	BUY	$2.2 - $4.46 $71,970 - $145,904	32,714 Added 2321.79%	34,123 $86,000
Q2 2021 Aug 12, 2021	BUY	$5.85 - $8.33 $8,242 - $11,736	1,409 New	1,409 $9,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.